Literature DB >> 19165451

[Delirium in a patient with cerebral metastasis].

Barbara Wiener1.   

Abstract

Delirium is a common complication in palliative care of preterminally or terminally ill cancer patients. Based on a case report of a delirious male patient with cerebral metastasis, typical manifestations, etiologies, risk factors and possible therapies of palliative delirium will be reviewed. Furthermore, difficult therapeutic decisions with regard to the use of corticosteroids, fentanyl and parenteral rehydration therapy will be discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19165451     DOI: 10.1007/s10354-008-0631-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  13 in total

1.  The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses.

Authors:  William Breitbart; Christopher Gibson; Annie Tremblay
Journal:  Psychosomatics       Date:  2002 May-Jun       Impact factor: 2.386

2.  Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.

Authors:  Kyriaki Mystakidou; Sofia Befon; Eleni Tsilika; Kostas Dardoufas; Stavroula Georgaki; Lambros Vlahos
Journal:  Oncology       Date:  2002       Impact factor: 2.935

3.  Relationship between etiology and phenomenologic profile in delirium.

Authors:  D J Meagher; D O'Hanlon; E O'Mahony; P R Casey; P T Trzepacz
Journal:  J Geriatr Psychiatry Neurol       Date:  1998       Impact factor: 2.680

Review 4.  Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.

Authors:  Hélène Lacasse; Marc M Perreault; David R Williamson
Journal:  Ann Pharmacother       Date:  2006-10-17       Impact factor: 3.154

Review 5.  Corticosteroids in cancer: neuropsychiatric complications.

Authors:  F C Stiefel; W S Breitbart; J C Holland
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

6.  Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.

Authors:  Tatsuya Morita; Chizuko Takigawa; Hideki Onishi; Tsukasa Tajima; Kazuhiko Tani; Tatsuhiko Matsubara; Izuru Miyoshi; Masayuki Ikenaga; Tatsuo Akechi; Yosuke Uchitomi
Journal:  J Pain Symptom Manage       Date:  2005-07       Impact factor: 3.612

7.  A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain.

Authors:  P A Sloan; D E Moulin; H Hays
Journal:  J Pain Symptom Manage       Date:  1998-08       Impact factor: 3.612

Review 8.  Delirium in palliative care.

Authors:  Miriam M Friedlander; Yanina Brayman; William S Breitbart
Journal:  Oncology (Williston Park)       Date:  2004-10       Impact factor: 2.990

9.  A comparison of subcutaneous morphine and fentanyl in hospice cancer patients.

Authors:  R Hunt; B Fazekas; D Thorne; M Brooksbank
Journal:  J Pain Symptom Manage       Date:  1999-08       Impact factor: 3.612

Review 10.  Delirium and dehydration: some fluid for thought?

Authors:  Peter G Lawlor
Journal:  Support Care Cancer       Date:  2002-02-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.